Patents by Inventor Otto Holst

Otto Holst has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11267841
    Abstract: The present invention generally relates to the field of detecting and preventing infectious diseases caused by Enterococcus faecalis and/or Enterococcus faecium.
    Type: Grant
    Filed: October 7, 2019
    Date of Patent: March 8, 2022
    Assignee: KLINIKUM DER UNIVERSITÄT MÜNCHEN
    Inventors: Johannes Hübner, Otto Holst, Christian Theilacker, Zbigniew Kaczynski
  • Patent number: 11179407
    Abstract: The present invention relates to L-arabino-oligosaccharides, in particular synthetically produced L-arabino-oligosaccharides and their uses for the prophylaxis of allergic reactions in mammals.
    Type: Grant
    Filed: November 30, 2016
    Date of Patent: November 23, 2021
    Assignees: FORSCHUNGSZENTRUM BORSTEL LEIBNIZ-ZENTRUM FÜR MEDIZIN UND BIOWISSENSHAFTEN, UNIVERSITÄT ROSTOCK, RUHR-UNIVERSITÄT BOCHUM
    Inventors: Marcus Peters, Otto Holst, Christian Vogel, Alice Voss
  • Publication number: 20200306279
    Abstract: The present invention relates to L-arabino-oligosaccharides, in particular synthetically produced L-arabino-oligosaccharides and their uses for the prophylaxis of allergic reactions in mammals.
    Type: Application
    Filed: November 30, 2016
    Publication date: October 1, 2020
    Inventors: Marcus PETERS, Otto HOLST, Christian VOGEL, Alice VOSS
  • Publication number: 20200048296
    Abstract: The present invention generally relates to the field of detecting and preventing infectious diseases caused by Enterococcus faecalis and/or Enterococcus faecium.
    Type: Application
    Filed: October 7, 2019
    Publication date: February 13, 2020
    Inventors: JOHANNES HÜBNER, OTTO HOLST, CHRISTIAN THEILACKER, ZBIGNIEW KACZYNSKI
  • Patent number: 9950017
    Abstract: The present invention relates to a pharmaceutical composition which includes naturally occurring, non-transgenic isolated bacteria from the group of Lactococcus and Acinetobacter or fragments thereof or mixtures thereof, to such a bacterium as a medicament for the prevention and/or treatment of allergic or chronic inflammatory disorders and to a process for producing this composition.
    Type: Grant
    Filed: March 3, 2008
    Date of Patent: April 24, 2018
    Assignees: FORSCHUNGSZENTRUM BORSTEL, RUHR-UNIVERSITÄT BOCHUM
    Inventors: Albrecht Bufe, Otto Holst, Harald Renz, Erika Von Mutius, Johann Bauer, Nicole Blumer, Jennifer Debarry, Markus Ege, Susanne Friedrich, Holger Garn, Soren Gatermann, Anna Hanuszkiewicz, Holger Heine, Michael Wegmann
  • Publication number: 20180009834
    Abstract: The present invention generally relates to the field of detecting and preventing infectious diseases caused by Enterococcus faecalis and/or Enterococcus faecium.
    Type: Application
    Filed: August 31, 2017
    Publication date: January 11, 2018
    Inventors: Johannes HÜBNER, Otto HOLST, Christian THEILACKER, Zbigniew KACZYNSKI
  • Patent number: 9796744
    Abstract: The present invention generally relates to the field of detecting and preventing infectious diseases caused by Enterococcus faecalis and/or Enterococcus faecium.
    Type: Grant
    Filed: November 13, 2007
    Date of Patent: October 24, 2017
    Assignee: UNIVERSITÄTSKLINIKUM FREIBURG
    Inventors: Johannes Hübner, Otto Holst, Christian Theilacker, Zbigniew Kaczynski
  • Patent number: 9750796
    Abstract: The present invention relates to enterococcal cell wall polymers and their uses in the prevention and therapy of bacterial infection.
    Type: Grant
    Filed: March 4, 2013
    Date of Patent: September 5, 2017
    Assignees: UNIVERSITAETSKLINKUM FREIBURG, FORSCHUNGSZENTRUM BORSTEL
    Inventors: Johannes Huebner, Otto Holst, Christian Theilacker, Karolina Kruszynska, Stefan Geiss-Liebisch, Agnieszka Beczala
  • Publication number: 20160296596
    Abstract: A prophylactic antiallergenic composition includes at least one arabinogalactan or arabinogalactan protein. The arabinogalactan or arabinogalactan protein is isolated from a grass or corresponds in its structural arrangement to an arabinogalactan that can be isolated from a grass.
    Type: Application
    Filed: June 20, 2016
    Publication date: October 13, 2016
    Inventors: Marcus Peters, Marion Kauth, Albrecht Bufe, Otto Holst
  • Patent number: 9375444
    Abstract: A prophylactic antiallergenic composition includes at least one arabinogalactan or arabinogalactan protein. The arabinogalactan or arabinogalactan protein is isolated from a grass or corresponds in its structural arrangement to an arabinogalactan that can be isolated from a grass.
    Type: Grant
    Filed: October 21, 2013
    Date of Patent: June 28, 2016
    Assignees: PROTECTIMMUN GMBH, FORSCHUNGSZENTRUM BORSTEL
    Inventors: Marcus Peters, Marion Kauth, Albrecht Bufe, Otto Holst
  • Patent number: 9255157
    Abstract: The present invention relates to a rhamno-polysaccharide antigen from Enterococcus faecium clonal complex which is useful as a vaccine component for therapy and/or prophylaxis of bacterial infection.
    Type: Grant
    Filed: May 25, 2012
    Date of Patent: February 9, 2016
    Assignees: Universitaetsklinikum Freiburg, Forschungszentrum Borstel
    Inventors: Johannes Hübner, Christian Theilacker, Zbigniew Kaczynski, Otto Holst
  • Publication number: 20150139998
    Abstract: The present invention relates to enterococcal cell wall polymers and their uses in the prevention and therapy of bacterial infection.
    Type: Application
    Filed: March 4, 2013
    Publication date: May 21, 2015
    Inventors: Johannes Huebner, Otto Holst, Christian Theilacker, Karolina Kruszynska, Stefan Geiss-Liebisch, Agnieszka Beczala
  • Patent number: 9005622
    Abstract: The present invention relates to enterococcal cell wall components and their uses in the prevention and therapy of bacterial infection.
    Type: Grant
    Filed: January 19, 2010
    Date of Patent: April 14, 2015
    Assignees: Forschungszentrum Borstel, Universitätsklinikum Freiburg
    Inventors: Johannes Hübner, Christian Theilacker, Otto Holst, Zbigniew Kaczynski
  • Publication number: 20140161792
    Abstract: The present invention relates to a rhamno-polysaccharide antigen from Enterococcus faecium clonal complex which is useful as a vaccine component for therapy and/or prophylaxis of bacterial infection.
    Type: Application
    Filed: May 25, 2012
    Publication date: June 12, 2014
    Applicants: FORSCHUNGSZENTRUM BORSTEL, UNIVERSIT TSKLINIKUM FREIBURG
    Inventors: Johannes Hübner, Christian Theilacker, Zbignew Kacynski, Otto Holst
  • Publication number: 20140154290
    Abstract: A prophylactic antiallergenic composition includes at least one arabinogalactan or arabinogalactan protein. The arabinogalactan or arabinogalactan protein is isolated from a grass or corresponds in its structural arrangement to an arabinogalactan that can be isolated from a grass.
    Type: Application
    Filed: October 21, 2013
    Publication date: June 5, 2014
    Applicants: FORSCHUNGSZENTRUM BORSTEL, PROTECTIMMUN GMBH
    Inventors: Marcus Peters, Marion Kauth, Albrecht Bufe, Otto Holst
  • Publication number: 20120282268
    Abstract: The present invention relates to enterococcal cell wall components and their uses in the prevention and therapy of bacterial infection.
    Type: Application
    Filed: January 19, 2010
    Publication date: November 8, 2012
    Inventors: Johannes Hübner, Christian Theilacker, Otto Holst, Zbigniew Kaczynski
  • Publication number: 20100055112
    Abstract: The present invention generally relates to the field of detecting and preventing infectious diseases caused by Enterococcus faecalis and/or Enterococcus faecium.
    Type: Application
    Filed: November 13, 2007
    Publication date: March 4, 2010
    Inventors: Johannes Hübner, Otto Holst, Christian Theilacker, Zbigniew Kaczynski
  • Publication number: 20080305089
    Abstract: The present invention relates to a pharmaceutical composition which includes naturally occurring, non-transgenic isolated bacteria from the group of Lactococcus and Acinetobacter or fragments thereof or mixtures thereof, to such a bacterium as a medicament for the prevention and/or treatment of allergic or chronic inflammatory disorders and to a process for producing this composition.
    Type: Application
    Filed: March 3, 2008
    Publication date: December 11, 2008
    Applicant: Protectimmun GmbH
    Inventors: Albrecht Bufe, Otto Holst, Harald Renz, Erika von Mutius, Johann Bauer, Nicole Blumer, Jennifer Debarry, Markus Ege, Susanne Friedrich, Holger Garn, Soren Gatermann, Anna Hanuszkiewicz, Holger Heine, Michael Wegmann
  • Publication number: 20080112983
    Abstract: The present invention describes a process for preparing an extract for the treatment of allergic diseases, in which process no heat is supplied during all of the preparation process, an extract which has been prepared by this process, and the use of this extract for preparing a medicament.
    Type: Application
    Filed: August 18, 2005
    Publication date: May 15, 2008
    Inventors: Albrecht Bufe, Otto Holst, Erika Von Mutius, Charlotte Braun-Fahrlander, Dennis Nowak, Josef Riedler